Informations techniques
Exploitant
Laboratoires PROSTRAKAN PHARMA
Présentation
DROLEPTAN 2,5 mg/ 1ml, solution injectable (IV) B/10 - CIP 561 122-8
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
BJ0TbqbYQjccxyLc